Statement: Pia Berghaus, Vice President, Möller Chemie

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

There are several challenges, for example, the demand for sustainability. Customers increasingly prioritize eco-friendly and sustainable products, which requires distributors to adapt their portfolios. Here, we can act as a bridge between suppliers and customers to promote green products.

Customers expect digital solutions for ordering, tracking, and communication, which pushes distributors to modernize rapidly. The digital transformation also requires investment in ERP systems and AI-driven inventory management.

For our customers and for ourselves it is important to offer value-added services. In this case, providing technical expertise, regulatory compliance support, and application development are key factors for having a long-term customer relationship. When we talk about technical expertise, we think of developing solutions with customers as it strengthens loyalty and differentiates the distributor.

If we look at the industry, we can clearly see that there is a consolidation trend. There are many mergers and acquisitions within Europe, which increase the competition for smaller players like us.  

Then it is necessary to mention the supply chain disruptions. Global challenges, such as geopolitical tensions and raw material shortages can affect inventory and logistics, but also the willingness for further investments.

For all the challenges and opportunities, we need the right people. We need the right people to be successful in our transformation. This is why talent development is crucial.

All in all, we can say, that the chemical distribution industry stands at a crossroads of challenges and opportunities. Investments in digital transformation, sustainability, and collaborative innovation are crucial for navigating uncertainties and unlocking growth potential. By embracing the role of solution providers, distributors can support both suppliers and customers in shaping a resilient and innovative future.

Pia Berghaus, Möller Chemie © Möller Chemie
Pia Berghaus, Möller Chemie © Möller Chemie

“Investments in digital transformation, sustainability, and collaborative innovation are crucial for navigating uncertainties and unlocking growth potential.”

Company

Möller Chemie GmbH & Co. KG

Bürgerkamp 1
48565 Steinfurt
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.